Describe Relations Between qCON and qNOX Indicies During Propofol-Remifentanil General Anesthesia

NCT06349681 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2024-04-25

No results posted yet for this study

Summary

CONOX is a neuromonitoring EEG- device for sedation (qCON) and analgesia (qNOX) monitoring during general anesthesia.

It is unknown on how the indicies can differentiate themselves so aim of this study is to determine the relationship bewtween the 2 indicies.

Conditions

  • Anesthesia Brain Monitoring

Sponsors & Collaborators

  • University of Padova

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-01
Primary Completion
2024-09-01
Completion
2024-10-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06349681 on ClinicalTrials.gov